Lantern Pharma Company
Clinical stage biotechnology companyLantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. It develops LP-100 for treatment in combination with the class of anticancer agent known as PARP inhibitors.Country: United StatesIndustry: BiotechnologyIPO Date: Jun 11, 2020Sector: HealthcareLantern Pharma Inc. (LTRN) Company Profile & Overview - Stock …stockanalysis.com/stocks/ltrn/company/
Founded Date:
2013
Industry:
Clinical Development
Headquarters:
Atlanta, Fulton County, Georgia, United States
Employee Number:
11-50